Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition:   COVID-19 Interventions:   Drug: Hydroxychloroquine;   Drug: Indomethacin;   Drug: Zithromax Oral Product Sponsors:   Perseverance Research Center, LLC;   Athena Medical Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition:   COVID-19 Interventions:   Drug: Hydroxychloroquine;   Drug: Indomethacin;   Drug: Zithromax Oral Product Sponsors:   Perseverance Research Center, LLC;   Athena Medical Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition:   COVID-19 Interventions:   Drug: Hydroxychloroquine;   Drug: Indomethacin;   Drug: Zithromax Oral Product Sponsors:   Perseverance Research Center, LLC;   Athena Medical Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials

Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing PEP
Condition:   Healthy Intervention:   Device: Pancreatic duct stenting Sponsor:   Fourth Military Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2020 Category: Research Source Type: clinical trials